PSAT1P3

Across TCGA pan-cancer cohorts, PSAT1P3 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of PSAT1P3’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where PSAT1P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PSAT1P3 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

COAD, BRCA, and UCEC are the cancer types where PSAT1P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PSAT1P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.200	<.001	8	view →
BRCA	All	III,IV	−0.711	<.001	6	view →
UCEC	All	IV	+0.185	.017	2	view →
LUAD	Male	All	+0.095	.016	1	view →
KICH	Male	IV	+0.066	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

PSAT1P3–COAD

Open the COAD breakdown →